Medivation Jumps on Prostate Cancer Drug Test (MDVN, DNDN, JNJ)
Shares of development-stage drug maker Medivation Inc. have risen sharply today as the company said that its MDV3100 late-stage prostate cancer drug for patients who have failed chemotherapy extends life expectancy by…